Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Amy Sussman
Professor, Medicine - (Clinical Scholar Track) | Vice Chair, Education
Medicine
Full Page
Overview
Research
More
Collaboration
(7)
Jarrod Mosier
Mutual work: 1 Publication
Collaboration Details
Vance Nielsen
Mutual work: 1 Publication
Collaboration Details
Erika Bracamonte
Mutual work: 7 Publications
Collaboration Details
Stephanie Soto
Mutual work: 2 Proposals﹒1 Grant
Collaboration Details
Katherine Mendoza
Mutual work: 1 Grant﹒2 Proposals
Collaboration Details
Page 1 of 2
Previous page
Next page
Grants
(5)
A Phase 3, Randomized, Placebo-Controlled, Double-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients with C3 Glomerulopathy or Immune-Complex Membranoprolifera
Active
·
2024
·
$29.9K / $7.5K
·
External
Principal Investigator (PI)
clinical trials,
kidney diseases,
drug safety,
immunology,
pharmacology
A Phase IIb Randomized, Double-Blinded, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of Atacicept in Subjects with IgA Nephropathy (IgAN)
Active
·
2022
·
$140.4K
·
External
Principal Investigator (PI)
clinical trials,
nephrology,
immunology,
drug safety,
pharmacology
A Randomized, Double-Blind, Placebo Controlled Study to Evaluate Efficacy and Safety of Nefecon in Patients with Primary IgA Nephropathy at Risk of Progressing to End-Stage Renal Disease (NefIgArd)
2019
·
$105.9K
·
External
Principal Investigator (PI)
nephropathy,
clinical trial,
renal disease,
treatment,
safety
A Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy
2014
·
$104K
·
External
Principal Investigator (PI)
nephropathy,
immunosuppressive,
rituximab,
cyclosporine,
randomized trial
Residency Training Program - Internal Medicine
2003
·
$14.2M
·
External
Principal Investigator (PI)
medical education,
internal medicine,
residency programs,
clinical training,
healthcare workplace
Publications
(29)
Recent
Programmed to Fail: The Decline of Protected Time for Training Program Administration
2023
medical education,
workplace efficiency,
residency programs,
time management,
administration challenges
Nephrology Program Director Protected Time for Program Administration in the United States
2022
nephrology,
medical education,
healthcare administration,
work-life balance,
medical leadership
Assessing Nephrology Fellows Skills in Communicating About Kidney Replacement Therapy and Kidney Biopsy: A Multicenter Clinical Simulation Study on Breaking Bad News.
2021
nephrology,
communication,
clinical simulation,
kidney replacement therapy,
skills assessment
Limited Significance of Antifactor H Antibodies in Patients with Membranous Nephropathy
2021
antibody research,
nephropathy,
immunology,
kidney disease,
medical research
An international cohort study of autosomal dominant tubulointerstitial kidney disease due to REN mutations identifies distinct clinical subtypes
2020
genetics,
kidney disease,
clinical subtypes,
mutation identification
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
2019
nephropathy,
rituximab,
cyclosporine,
treatment,
membranous
Proliferative Glomerulonephritis With Masked Monoclonal Deposits Responsive to Myeloma Therapy
2017
glomerulonephritis,
monoclonal deposits,
myeloma therapy,
proliferative,
responsive
Decreasing After-Hours Hemodialysis in Hospitals
2016
hemodialysis,
hospital care,
after-hours care,
healthcare efficiency,
patient outcomes
Acute oxalate nephropathy due to pancreatic atrophy in newly diagnosed pancreatic carcinoma
2016
nephropathy,
pancreatic carcinoma,
oxalate,
pancreatic atrophy,
acute
Membranous nephropathy with crescents associated with levamisole-induced MPO-ANCA vasculitis
2016
nephropathy,
vasculitis,
levamisole,
mpo-anca,
membranous
